Tricida, Inc. (TCDA) financial statements (2021 and earlier)

Company profile

Business Address 7000 SHORELINE COURT, SUITE 201
SOUTH SAN FRANCISCO, CA 94080
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments310308241
Cash and cash equivalents1381937
Short-term investments172289204
Other undisclosed current assets453
Total current assets:314313244
Noncurrent Assets
Operating lease, right-of-use asset149
Property, plant and equipment131
Long-term investments and receivables23472
Long-term investments23472
Total noncurrent assets:38594
TOTAL ASSETS:352372248
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities323915
Accounts payable468
Accrued liabilities29336
Debt 1 
Other undisclosed current liabilities2  
Total current liabilities:344015
Noncurrent Liabilities
Long-term debt and lease obligation906738
Long-term debt, excluding current maturities775838
Operating lease, liability139
Liabilities, other than long-term debt010
Other liabilities010
Other undisclosed noncurrent liabilities119  
Total noncurrent liabilities:2096839
Total liabilities:24310853
Stockholders' equity
Stockholders' equity attributable to parent109264195
Common stock000
Additional paid in capital743633387
Accumulated other comprehensive income (loss)00(0)
Accumulated deficit(634)(369)(192)
Total stockholders' equity:109264195
TOTAL LIABILITIES AND EQUITY:352372248

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Gross profit:0  
Operating expenses(251)(179)(104)
Other undisclosed operating loss(0)  
Operating loss:(251)(179)(104)
Nonoperating income
(Other Nonoperating income)
584
Interest and debt expense(18)(6)(3)
Loss from continuing operations before income taxes:(265)(177)(103)
Income tax benefit 0 
Net loss available to common stockholders, diluted:(265)(177)(103)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Net loss:(265)(177)(103)
Comprehensive loss:(265)(177)(103)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)0(0)
Comprehensive loss, net of tax, attributable to parent:(265)(176)(103)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: